Published: Guidance, quality standards and advice
Showing 1 to 5 of 5
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies | TA786 | ||
| Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer | TA263 | ||
| Capecitabine for the treatment of advanced gastric cancer | TA191 | ||
| Capecitabine and oxaliplatin in the adjuvant treatment of stage 3 (Dukes' C) colon cancer | TA100 | ||
| Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer | TA61 |